{"organizations": [], "uuid": "2d65027a6eafa86ee876eb55082bc2cc49ff4902", "thread": {"social": {"gplus": {"shares": 0}, "pinterest": {"shares": 0}, "vk": {"shares": 0}, "linkedin": {"shares": 0}, "facebook": {"likes": 0, "shares": 0, "comments": 0}, "stumbledupon": {"shares": 0}}, "site_full": "www.cnbc.com", "main_image": "", "site_section": "http://www.cnbc.com/id/10000551/device/rss", "section_title": "California", "url": "https://www.cnbc.com/2018/05/04/the-associated-press-acadia-1q-earnings-snapshot.html", "country": "US", "domain_rank": 767, "title": "Acadia: 1Q Earnings Snapshot", "performance_score": 0, "site": "cnbc.com", "participants_count": 1, "title_full": "", "spam_score": 0.0, "site_type": "news", "published": "2018-05-04T15:51:00.000+03:00", "replies_count": 0, "uuid": "2d65027a6eafa86ee876eb55082bc2cc49ff4902"}, "author": "cnbc.com", "url": "https://www.cnbc.com/2018/05/04/the-associated-press-acadia-1q-earnings-snapshot.html", "ord_in_thread": 0, "title": "Acadia: 1Q Earnings Snapshot", "locations": [], "entities": {"persons": [], "locations": [{"name": "san diego", "sentiment": "none"}], "organizations": [{"name": "acadia pharmaceuticals inc.", "sentiment": "negative"}, {"name": "ap", "sentiment": "negative"}, {"name": "zacks investment research", "sentiment": "none"}, {"name": "acadia", "sentiment": "none"}]}, "highlightText": "", "language": "english", "persons": [], "text": "SAN DIEGO (AP) _ Acadia Pharmaceuticals Inc. (ACAD) on Friday reported a loss of $54.3 million in its first quarter.\nThe San Diego-based company said it had a loss of 44 cents per share.\nThe results surpassed Wall Street expectations. The average estimate of five analysts surveyed by Zacks Investment Research was for a loss of 56 cents per share.\nThe drugmaker posted revenue of $48.9 million in the period, also topping Street forecasts. Three analysts surveyed by Zacks expected $46.7 million.\nAcadia expects full-year revenue in the range of $255 million to $270 million.\nAcadia shares have decreased 47 percent since the beginning of the year. The stock has fallen 51 percent in the last 12 months.\nThis story was generated by Automated Insights ( http://automatedinsights.com/ap ) using data from Zacks Investment Research. Access a Zacks stock report on ACAD at https://www.zacks.com/ap/ACAD", "external_links": ["https://www.zacks.com/ap/ACAD", "http://automatedinsights.com/ap"], "published": "2018-05-04T15:51:00.000+03:00", "crawled": "2018-05-04T18:41:05.000+03:00", "highlightTitle": ""}